| Drug General Information |
| Drug ID |
D0M8FD
|
| Former ID |
DCL000994
|
| Drug Name |
SNDX-275
|
| Synonyms |
Entinostat; Histone Deacetylase Inhibitor I; IN1470; MS 275; SNDX 275; MS 27-275; Ms-275; Entinostat (USAN/INN); MS-27-275; Pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate; Pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate; Pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate; Pyridin-3-ylmethyl{4-[(2-aminophenyl)carbamoyl]benzyl}carbamate; Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester; Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester; Entinostat, SNDX-275, MS-27-275, MS-275; N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide; N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide; Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester; 3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate
|
| Drug Type |
Small molecular drug
|
| Company |
Bayer Schering
|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C21H20N4O3
|
| InChI |
InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)
|
| InChIKey |
INVTYAOGFAGBOE-UHFFFAOYSA-N
|
| CAS Number |
CAS 703-95-7
|
| PubChem Compound ID |
|
| PubChem Substance ID |
529250, 4361630, 8152650, 11442374, 12015232, 14804341, 26758879, 29217590, 29217591, 29223361, 46519433, 50069042, 50875267, 53788084, 53800910, 56312377, 56312987, 57322216, 68529926, 85736423, 87226500, 93309933, 96026018, 99430926, 99436959, 103031574, 103197084, 103846864, 104305887, 117537663, 124756966, 124893190, 125163771, 125333791, 126626762, 126666975, 127325713, 127325714, 127325715, 127325716, 127325717, 128194857, 131305022, 131465123, 134338847, 134339425, 134964213, 135105768, 135314784, 135727398
|
| Target and Pathway |
| References |
